DuPont de Nemours, IncNYSE: DD
Materials · Specialty Chemicals
$47.82
-0.28%
Vol: 3.0M
Research Digest
Friday, June 19, 2026
DuPont executed a 1-for-3 reverse stock split effective June 24 and reaffirmed full-year 2026 EPS guidance of $7.02-$7.16 on ~137M diluted shares.
DuPont de Nemours' board approved a 1-for-3 reverse stock split following stockholder approval at its May 21, 2026 annual meeting, effective June 24, 2026, consolidating every three shares into one. The company simultaneously reaffirmed its 2026 sales guidance of approximately $7.08B-$7.14B and adjusted Q2 EPS of ~$1.75, with full-year adjusted EPS of $7.02-$7.16 on ~137 million diluted shares. DuPont also announced its U.S. healthcare manufacturing operations are now 100% renewable electricity-supplied, and its MemCor MBR technology was selected for Sydney's Riverstone Water Resource Recovery Facility on June 9. The company plans to buy back $275 million of stock. Risk: a reverse split is often viewed cautiously by the market; watch for share price response post-effective date June 24.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21DuPont seeks shareholder vote on 1-for-2 to 1-for-4 reverse stock split at May 21 annual meetingMixed▶
DuPont annual meeting on May 21 will ask shareholders to approve a reverse stock split in a range of 1-for-2 to 1-for-4, a significant corporate-structure decision. The company recently completed the April 1 divestiture of its Aramids business with $300M note plus cash, and an accelerated $275M share repurchase is planned. Q1 2026 results on May 5 showed adjusted EPS of $0.55 (beat by $0.07), revenue of $1.68B (+4%), and management raised FY26 net sales guidance to $7.155-7.215B and completed a $500M buyback. Shares jumped 11.4% on the print but have pulled back 7.9% over the last 7 days. RBC, Deutsche Bank, and UBS each raised PTs to ~$60. Risk: reverse split could be interpreted as defensive; aramids divestiture removes a meaningful business.
May 20DuPont stock approaches May 21 annual meeting with reverse stock split vote after Q1 beat and raised 2026 guidancePositive▶
DuPont de Nemours heads into its May 21, 2026 annual meeting where shareholders will vote on a proposed reverse stock split in a 1-for-2 to 1-for-4 range. Q1 2026 results delivered EPS of $0.36 (up from $0.17), revenue of $1.68B (+4.3% YoY), and net income up 104%, with management raising full-year 2026 sales guidance to $7.155B-$7.215B. The company completed a $500M share repurchase program (12.2M shares, 2.93% of stock) and authorized an additional $275M buyback. Multiple analysts raised price targets in early May, including RBC to $60, Deutsche Bank to $60, and UBS to $59. Consensus rating is now Strong Buy as the refocused portfolio in electronics, healthcare, and water tech gains traction.
May 19No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 18DuPont reported Q1 EPS of $0.55 beating estimates by $0.07, raised FY26 sales guidance to $7.155-$7.215B and completed $500M buyback, sending shares up 11.4%.Positive▶
On May 5, 2026, DuPont reported Q1 2026 results with net sales of $1.681B (up 4% YoY, 2% organic), operating EBITDA up 15% to $414M, and adjusted EPS up 53% to $0.55 (beating estimates by $0.07). Cash from operations surged 201% to $232M. The company raised full-year 2026 net sales guidance to $7.155-$7.215B and adjusted EPS guidance to $2.35-$2.40, citing 4% organic sales growth with pricing actions offsetting higher Middle East-related input costs. DuPont completed its $500M share repurchase program covering 12,228,858 shares (2.93% of stock). Shares surged 11.4% on the news. RBC Capital raised PT to $60 (from $56) on May 11; Deutsche Bank raised to $60 (from $58) on May 7; UBS raised to $59 (from $56).
May 15DuPont de Nemours surged 11.4% after raising FY26 sales guidance to $7.155-$7.215B and completing a $500M buyback covering 2.93% of shares.Positive▶
DuPont de Nemours has rallied 11.4% in May 2026 after raising its full-year 2026 net sales guidance to $7,155-$7,215 million and completing a $500 million share buyback that retired 12,228,858 shares (2.93% of stock). Q1 2026 results released May 5 showed net sales of $1.68B up 4% YoY (organic +2%), operating EBITDA up 15% to $414M, adjusted EPS up 53% to $0.55 (beating estimates by $0.07), and operating cash flow surging 201% to $232M. FY26 adjusted EPS guide raised to $2.35-$2.40 with 4% organic growth expected and pricing actions offsetting higher Middle East-related input costs. The Electronics segment is driving growth via semiconductor materials and Water is benefiting from infrastructure demand. Quarterly dividend of $0.20 payable May 29 (ex-date May 15). Risk: global trade-policy and feedstock-cost volatility could pressure margins later in the year.
May 14DuPont raised 2026 sales guidance to $7.16-$7.22B and announced new $275M ASR after Q1 beat; RBC raised PT to $60 on May 11Positive▶
DuPont reported Q1 2026 net sales of $1.681B, operating EBITDA of $414M, and adjusted EPS of $0.55, raising full-year sales guidance to $7,155M-$7,215M. The company completed a $500M repurchase of 12.2M shares (~2.93% of stock) and announced an additional $275M accelerated share repurchase imminently. The Aramids divestiture closed April 1 with proceeds including a $300M note receivable and equity in New Arclin. RBC raised PT to $60 (May 11), Deutsche Bank to $60 (May 7), UBS to $59. Shares surged 11.4% on the print and traded $50.59 on May 11. Risk: industrial demand softness and tariff exposure offset.
May 13DuPont raised FY2026 EPS guidance to $2.35-$2.40 and accelerated a $500M buyback after Q1 EPS jumped 52.8% to $0.55, with several analysts raising price targets in early May.Positive▶
DuPont reported Q1 2026 net sales of $1.681B and adjusted EPS of $0.55, up 52.8% YoY, beating EPS estimates while revenue was light. The company raised FY2026 sales guidance to $7.155B-$7.215B and adjusted EPS to $2.35-$2.40, above the $2.27 consensus. DuPont completed its Aramids divestiture on April 1 for ~$1.2B cash plus a $300M note, and finished a $500M accelerated share buyback. Healthcare & Water Technologies sales rose 6% to $806M; Diversified Industrials rose 3% to $875M. Deutsche Bank raised PT to $60, UBS to $59, and BMO reiterated Buy. Stock closed at $49.76 on May 8.
May 12DuPont raised FY26 net sales guidance to $7,155M-$7,215M after Q1 EPS beat (adj $0.55) and $500M buyback completion; RBC raised PT to $60 from $56 on May 11 maintaining Outperform.Positive▶
DuPont de Nemours reported Q1 2026 sales of $1,681M with operating EBITDA of $414M and adjusted diluted EPS of $0.55, beating consensus and returning to profitability. The company raised full-year 2026 net sales guidance to $7,155M-$7,215M and Q2 EPS guidance to $0.59, FY26 EPS to $2.35-$2.40. DuPont completed a $500M share repurchase program (2.93% of shares) and finalized the Aramids business divestiture on April 1. Shares rose 5.9% on the report. On May 11, RBC Capital's Arun Viswanathan raised the price target to $60 from $56, maintaining Outperform.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| SHWSHERWIN | $321.36 | +2.41% | +2.4% | 26.6x | 1.10 | $86.9B |
| ECLECOLAB | $269.94 | +0.33% | +1.7% | 29.6x | 0.90 | $79.7B |
| PPGPPG | $118.25 | +0.95% | +3.3% | 14.4x | 1.04 | $27.9B |
| IFFINTL | $76.96 | +1.19% | +5.8% | 17.4x | 0.94 | $21.4B |
| DDDUPONT | $47.82 | -0.28% | +3.1% | 17.8x | 1.08 | $18.9B |
| LYBLYONDELLBASELL | $59.94 | -3.03% | +1.4% | 7.8x | 0.36 | $17.2B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price between 50d and 200d. Testing 50d support.